作者: Richard A. Bond , Mitchell Glass
DOI:
关键词:
摘要: The chronic use of p-adrenergic inverse agonists such as nadolol, carvedilol, and ICI-118,551 provides an improved method for the treatment mucus hypersecretion in subjects with hypersecretion. One aspect a according to present invention is preventing or controlling respiratory tract comprising administering therapeutically effective quantity agonist subject at risk further encompasses pharmaceutical compositions additional compound.